D. E. Shaw & Co., Inc. Red Hill Biopharma Ltd. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$6.34 - $8.8 $85,913 - $119,248	-13,551 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$6.06 - $9.0 $120,860 - $179,496	-19,944 Reduced 59.54%	13,551 $113,000
Q4 2018 Feb 14, 2019	BUY	$5.18 - $9.35 $173,504 - $313,178	33,495 New	33,495 $186,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.